Breast Cancer

The goal of cancer immunotherapy is to improve the body’s natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with nutritional, endocrine measures and supplements.

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed i.e. Breast malignant cells.

T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.

T-cell Modulators contains several immunoactive components that have been shown to act synergistically in raising Dendritic and NK function and also effective as adjuvant therapy in Breast cancer treatments, elevating dendritic and NK function as much as 250%.

Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, B17, vitamin C, chemotherapy or radiotherapy.

In a group of patients with superficial breast cancer and chest wall recurrence, the addition of hyperthermia to their treatment increased local tumor eradication, and recurrence.

Mistletoe helps fight tumor-induced immune suppression. Natural killer cells (NK) are a type of white blood cell that looks for and destroys breast cancer cells. Research has shown that NK cells can spontaneously recognize and kill a variety of breast cancer cells.

Mistletoe has been called a “biological response modifier” due to its ability to improve various aspects of immune function. Studies show that it activates natural killer cells, T cells, macrophages and monocytes.

A special proprietary form of liposomal mistletoe created with nanotechnology has been created for use in our breast cancer treatment approach.

Glutathione is the most important antioxidant produced by your body and a master detoxifier of every cell in your body. It prevents cellular damage caused by free radicals and peroxides.

Glutathione metabolism is able to play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. However, by conferring resistance to a number of chemotherapeutic drugs, elevated levels of glutathione in tumor cells are able to protect such cells

A typical diet, characterized by dependence on animal products, refined carbohydrates and unhealthy fats such as processed vegetable oils, can promote an inflammatory environment in the body. A pro-inflammatory diet has been associated with an increased risk of breast cancer and an increased risk of death from breast cancer.

We custom-make a diet targeted to enhance the immune system’s ability to heal and provide our patients with the right nutrition for their current and long-term needs.

Breast cancer patients who take supplemental vitamins, including vitamin C, are 22% less likely to have a recurrence of breast cancer after treatment than those who do not take supplements. Women who take vitamin C after diagnosis are 15% less likely to die of the disease than those who do not take the supplement.

In one study, selenium levels were measured in the blood of 546 patients with a recent diagnosis of breast cancer. Women with the lowest levels of selenium were more than twice as likely to die during the five-year follow-up than women with the highest levels. A second study found that breast cancer patients with high dietary selenium intake were significantly less likely to die from the disease.

We use intravenous selenium as part of our breast cancer treatment approach.